James Bond, MD
Orthopaedic Surgery · Norman, OKNPI 1194753210
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (43.5%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. Smith+Nephew accounts for 64.5% of it on its own, with 7 other manufacturers making up the rest.
Across 61 payments — averaging $265.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$10K
- Medacta USA, Inc.$5K
- Stryker$142
- Bioventus LLC$126
- Vericel Corporation$76
- Johnson & Johnson$68
- plus $58 from 2 others
What the payments were for
- Consulting fees$9206%
- Speaking & faculty fees$6,72842%
- Travel & lodging$7,03243%
- Food & beverage$1,4999%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 20 | $10,434 |
| Medacta USA, Inc. | 18 | $5,274 |
| Stryker | 4 | $142 |
| Bioventus LLC | 8 | $126 |
| Vericel Corporation | 4 | $76 |
| Johnson & Johnson | 4 | $68 |
| Innovation Technologies Inc | 2 | $47 |
| Amgen | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TWINFIX$7,340
- PRIMARY SHOULDER$3,276
- GMK SPHERE$1,713
- Bioinductive Implant with Arthroscopic Delivery System - Medium$1,209
- Endobutton$1,081
- Mini-Open Latarjet$1,081
- TITAN-SHOULDER$1,037
- Healicoil$438
- TITAN$268
- TITAN TOTAL SHOULDER SYSTEM$268
- SPATIAL FRAME$128
- LENS 4K$128
How this compares
$16,178 in reported general payments places this provider in the 75th percentile of 263 orthopaedic surgery providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 227 | $2,617 |
| Cyclobenzaprine Hcl | 191 | $963 |
| Promethazine Hcl | 114 | $601 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 21 | $243 |
| Tramadol Hcl | 34 | $130 |
| Methylprednisolone | 12 | $103 |
| Amoxicillin | 11 | $14 |
| Diazepam | 11 | $11 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Norman
- Vytautas RingusNorman$272K
- Joshua WilsonNorman$40K
- Jeremiah MaupinNorman$20K
- Yogesh MittalTulsa$6.6M
- Andrew ParkinsonOklahoma City$3.1M
- Bradley ReddickOklahoma City$573K
- Jason EmersonOklahoma City$189K
- Brian ChalkinTulsa$183K
- Ronald DumiganOklahoma City$169K
- Kasra AhmadiniaTulsa$138K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.